Introduction: To investigate the relation between left atrial (LA) volume, sphericity, and fibrotic content derived from contrast-enhanced cardiac magnetic resonance imaging (CE-CMR) and their impact on the outcome of catheter ablation for atrial fibrillation (AF).
INTRODUCTION
Pulmonary vein isolation is a potentially curative treatment option for patients with atrial fibrillation (AF). 1 However, despite the many technological developments in recent years, the success rate of these procedures remains to be wanting. 2 Identifying patients who will benefit from this treatment is imperative to improve its success rate. Moreover, identification of patients with a low likelihood to benefit from pulmonary vein isolation alone allows the electrophysiologist to plan a more comprehensive ablation approach in order to improve the outcome.
Left atrial (LA) remodelling is thought to limit the efficacy of catheter ablation for AF: the more diseased the atria are, the less likely a patients is to benefit. 3, 4 Traditionally, the degree of atrial remodelling was assessed by measurement of the LA diameter. 5, 6 Figure 1. First, endocardial and epicardial contours of the LA were semi-automatically traced in each axial image. Second, in order to minimize endocardial and epicardial segmentation artefacts, ADAS R constructed a mid-myocardial layer (50% thickness) into a 3D shell of the LA. The mitral valve leaflets were used as landmarks to separate the LA from the left ventricle and the LA appendage and the pulmonary veins were excluded at their ostia, defined as the site of reflection of these F I G U R E 1 After acquisition, all CE-CMR data were exported to the ADAS R program for off-line postprocessing (A). After semiautomatic tracing of the endocardial and epicardial contours, the system constructed a mid-myocardial layer in which it calculated the signal intensity of the LA wall normalized to the blood pool intensity (IIR) (B). A 3D shell of the midmyocardial layer was created that was color-coded according to the IIR (C). From this 3D shell the LA volume, LA sphericity and LA fibrotic content were calculated (D) [Color figure can be viewed at wileyonlinelibrary.com] structures with the surrounding LA wall. Next, the signal intensity of the LA wall was normalized to the blood pool intensity by calculating the Image Intensity Ratio (IIR) and projecting the color-coded values onto the 3D mid-myocardial shell of the LA. Based on previous work of our group, 8 and ≤35%, UTAH IV: >35%). 9 Finally, the software calculated the LA volume and LA sphericity from the 3D shell. The LA sphericity is a measure for the difference in shape between the actual LA and a theoretical sphere-shaped LA. 7 The radius of this theoretical sphere equals the average radius (AR) between the endocardial borders and the center of mass of the actual LA. To determine the LA sphericity, the AR and the standard deviation of the AR are used to calculate the coefficient of variation (AR standard deviation/AR). Successively, LA sphericity is calculated using the following formula ([1 -coefficient of variation] x 100). All analyses were performed blinded to the clinical parameters.
A perfect sphere-shaped LA has a sphericity value of 100, with lower values for those atria adopting nonspherical contours. It is thought that the remodelling process involves a progressive change in atrial morphology that evolves from discoid-shaped to sphere-shaped, thereby progressively increasing the sphericity value. Previous work by our group has shown that a high LA sphericity value is associated with a higher risk for AF recurrence after ablation and improves the performance of the CHADS-VASc score in stroke prediction. 7,10
Catheter ablation
All ablation procedures were performed under deep sedation. After venous access through the femoral vein, a double transseptal puncture was performed to acquire access to the LA. A bolus of heparin (5,000-6,000 IU, according to patient weight) was then administered, as well as an additional bolus, to maintain an activated clotting time of 250-300 seconds. A circular mapping catheter (LASSO R , Biosense
Webster, Daimond Bar, CA, USA) was introduced inside the LA to assess pulmonary vein conduction.
Catheter ablation was either performed using radiofrequency or a cryoballoon. Both procedures have been described previously. 7, 11 In brief, during the procedures with a cryoballoon, the catheter (Arctic 
Follow-up
After ablation, all patients were evaluated on a regular basis at the outpatient clinic (1, 3, 6 , and 12 months). ECG recordings were acquired each visit as well as 24-hour ECG Holter monitoring. In addition to these routine visits, patients were encouraged to immediately obtain an ECG registration when experiencing palpitations. After a blanking period of 3 months, recurrence of AF was defined as any recording of AF on ECG or an episode longer than 30 seconds on 24-hour ECG Holter registration. 1
Statistical analyses
All variables were tested for a normal distribution with the Shapiro- to determine the optimal cut-off value for the strongest independent predictor to predict AF recurrence, based on the highest combined sensitivity and specificity. Furthermore, Kaplan-Meier plots were created and the log-rank test was performed to test the difference in AF recurrence after ablation using these cut-off values. All statistical analyses were performed with SPSS software (version 23.0, IBM Corporation, Armonk, NY, USA). A value of P < 0.05 was considered statistically significant.
RESULTS
A total of 83 patients (64 men [77%], mean age 55.8 ± 10.1 years) were included in this study. Baseline characteristics are shown in Table 1 .
The median duration of AF was 36 months (IQR 34). AF was paroxysmal in 43 patients (52%), persistent in 38 patients (46%), and longstanding persistent in 2 patients (2%), according to current guideline definitions. 12 In 73 patients (87%), ablation was performed using a radiofrequency catheter and in 10 patients (12%) using a cryoballoon catheter. The procedural endpoint of pulmonary vein isolation was reached in all patients. No major procedural complications were observed, while minor complications occurred in 5 patients (Table 1) .
LA volume, sphericity, and fibrotic content
The median LA volume on CMR was 94.4 mL (IQR 43.8), mean LA sphericity was 79.2 ± 3.2, and median LA fibrotic content was 6.2 cm 2 (IQR 8.9), corresponding to a median 6.0% (IQR 6.7) of the LA surface.
The LA volume was significantly higher in patients with nonparoxys- LA fibrotic content classification
• UTAH I (<5% of LA surface), n (%) 31 (37%)
• UTAH II (5-20% of LA surface), n (%) 46 (55%)
• UTAH III (20-35% of LA surface), n (%) 3 (4%)
• UTAH IV (>35% of LA surface), n (%) 3 (4%) sphericity (R = 0.535, P < 0.001, Figure 2A ). Furthermore, a weak but significant correlation was found between LA volume and LA fibrotic content (R = 0.241, P = 0.029, Figure 2B ).
Follow-up after catheter ablation
After a follow-up of 12 months, 60 patients (72%) had maintained stable sinus rhythm after a mean of 1.3 ± 0.6 procedures. The success rate after one ablation procedure was 57%. At 12 months of follow-up, antiarrhythmic drugs had been discontinued in 48 patients (80%) with stable sinus rhythm. There was no difference in the recurrence rate between radiofrequency catheter ablation and cryoballoon ablation (30% vs. 10%, respectively, P = 0.182). Moreover, there was no significant difference in recurrence rate between patients without additional ablation lesions, patients with additional linear lesions and Multivariate analyses demonstrated that that LA volume was the strongest and only independent predictor of AF recurrence after catheter ablation (Table 3 ). ROC analyses demonstrated that the opti- 
DISCUSSION
The present study investigated the impact of LA volume, sphericity, and fibrotic content on the outcome of catheter ablation for AF. Our results demonstrate that these LA remodelling markers are closely associated with each other. The most important finding of this study is that, despite this close association, LA volume is the strongest independent predictor of AF recurrence after catheter ablation.
LA structural remodelling
LA remodelling is a complex process of structural and electrical changes that determines the susceptibility of the heart to develop and perpetuate AF. 13, 14 A higher extent of LA remodelling limits the efficacy of catheter ablation for AF. 3, 4 Therefore, markers of LA remodelling have been used to predict the outcome of catheter ablation for AF by different groups. 4, 5 LA dilatation is one of the hallmarks of LA remodelling and has been long since recognized as a predictor of AF recurrence after catheter ablation. More recently, LA sphericity and LA fibrosis were reported to yield additive information leading to a more comprehensive assessment of LA remodelling and eventually improvement of the prediction of AF recurrence after ablation. 7, 9 The present study demonstrated that there is a clear association between LA volume, LA sphericity, and LA fibrosis: a higher extent of LA dilatation is related to a more sphere-shaped LA with a higher degree of fibrosis. Nevertheless, these associations are of a weak to moderate intensity, suggesting that to a certain extent they reflect dif-
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Kaplan-Meier curve for freedom of atrial fibrillation (AF) after catheter ablation according to left atrial volume <93.0 mL or ≥93.0 mL ferent processes contributing to atrial remodelling. This is in agreement with computational models that demonstrated that both atrial dilation and fibrotic content independently contribute to structural remodelling of the atria and the incidence of AF. 15, 16 Atrial morphology as a sign of remodelling has also been studied, 17 but clear proof of a direct arrhythmogenic effect is still lacking.
Currently it is unclear whether LA volume, LA sphericity, and LA fibrotic content follow a linear relationship during the process of atrial remodeling. There are suggestions that this might not be the case. 18 In agreement with these findings, the current population contained a subgroup of patients with a remarkable high degree of LA fibrosis in the presence of non-or mildly dilated atria ( Figure 2B ). Our results demonstrate that LA volume was a stronger predictor of AF recurrence after catheter ablation than LA sphericity and LA fibrosis. To our knowledge, this is the first time that the relation between these markers of LA remodelling is studied, as well as their relative impact on the outcome of catheter ablation for AF.
Previous work by Bisbal et al. also demonstrated that there is a relation between LA dilatation and LA sphericity. 7 Different to our study, they found that LA sphericity was a stronger predictor of AF recurrence than LA volume. However, in their study the mean LA volume was considerably smaller than in the present study (81.8 ± 26 mL vs. 
LIMITATIONS
The current study represents a consecutive group of patients who underwent CE-CMR prior to a catheter ablation for AF, when CE-CMR was available. Additional research should be performed to confirm these results. Moreover, there could be a different prognostic impact of LA volume, LA sphericity, and LA fibrotic content on the outcome of AF ablation in patients with relatively less remodeled atria than in severely diseased atria. Since the prevalence of severely diseased atria with a high degree of fibrosis (UTAH IV) is relatively low, the current study is most likely underpowered to demonstrate the prognostic impact of fibrotic content on the outcome of AF ablation. Therefore, further studies should be performed in patients with different stages of atrial disease before drawing final conclusions. Furthermore, the detection of AF recurrence after catheter ablation was based on Holter registrations acquired on a systematic basis. Importantly, patients were encouraged to obtain an ECG registration when experiencing palpitations in order to confirm AF as the cause of these complaints.
Nevertheless, asymptomatic episodes may have been missed.
CONCLUSION
LA volume, LA sphericity, and LA fibrotic content are closely related.
However, LA volume is the strongest independent predictor of AF recurrence after catheter ablation. 
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